Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2008
07/23/2008EP0831769B2 Novel uses for thyroid hormones or thyroid hormone-like compounds
07/23/2008CN101228275A Glycosylated il-7, preparation and uses
07/23/2008CN101228186A TFPI fragments as anti-microbial agents
07/23/2008CN101228183A Method of purifying APO-2 ligand/TRAIL using crystallisation in the cold
07/23/2008CN101228182A Antibakterielle amid-makrozyklen v
07/23/2008CN101228181A HCV NS3 protease inhibitors
07/23/2008CN101228179A A process for the preparation of perindopril erbumine
07/23/2008CN101228178A Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
07/23/2008CN101228169A Macrocyclic inhibitors of hepatitis c virus
07/23/2008CN101227918A Peptides and peptide simulacrums to treat pathologies characterized by an inflammatory response
07/23/2008CN101227836A Lycopene formulations for the treatment of atherosclerotic conditions
07/23/2008CN101225397A Construction of fusion gene pronucleus vector for IL-24 and EGF and uses thereof
07/23/2008CN101225391A Recombinant human interferon regulatory factor 4 binding protein expression system as well as preparation method and uses thereof
07/23/2008CN101225109A Tumour soluble antigen and staphylococcus aureus superantigen constructed tumor vaccine
07/23/2008CN101225107A Polypeptide organic compound and use thereof in hetero transplantation
07/23/2008CN101225106A Short peptide suppressing growth of cancer cell and uses thereof
07/23/2008CN101225105A Miscellaneous fish enzymolysis polypeptide and uses thereof
07/23/2008CN101225101A Preparation technology of promoting hepatocyte growth factor solution
07/23/2008CN101224300A Application of colon bacillus OmpA as animal immunity regulator
07/23/2008CN101224299A Preparing method of compounds capable of inducing tumor cell apoptosis
07/23/2008CN101224298A Propofol compounds
07/23/2008CN101224297A Application of recombinant human endostain in preparing medicine
07/23/2008CN101224296A Stable recombinant human endostain preparation and preparing method thereof
07/23/2008CN101224187A Dual functional polymer nanometer glue bunch and preparing method and application in preparing medicine for treating second narrow blood vessel
07/23/2008CN100404683C Human FL polynucleotide and use of human GM-CSF united gene therewith for treating malignant tumor
07/23/2008CN100404682C Amphioxus dimethyl arginine hydrolase AmphiDDAH gene and its application
07/23/2008CN100404677C Method for producing recombinant interleukin for animal
07/23/2008CN100404673C Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity
07/23/2008CN100404552C 因子Ⅷ多肽 Factor Ⅷ polypeptide
07/23/2008CN100404551C Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
07/23/2008CN100404550C Gene MgPTH12 for controlling mature and pathogenicity of fungi appressorium derived from Magnaporthe grisea and its uses
07/23/2008CN100404548C Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
07/23/2008CN100404547C Protein purification by ion exchange chromatography
07/23/2008CN100404069C Application of edestin in preparation of anti-anoxia functional food
07/23/2008CN100404068C Injection solution comprising an LHRH antagonist
07/22/2008US7402664 Nucleic acids and expression vectors comprising carotenoid binding peptides
07/22/2008US7402663 Obesity, antidiabetic agents
07/22/2008US7402661 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
07/22/2008US7402660 Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a TEM protein
07/22/2008US7402659 Recombinant cytokine for diagnosis, prevention and treatment of tissue-degenerating disorders
07/22/2008US7402658 TRAIN-R: a cysteine-rich member of the TNF-receptor family
07/22/2008US7402657 C-C chemokine receptor 3 proteins
07/22/2008US7402655 Nucleotide sequences coding polypeptide for use in the treatment of canccer, inflamation and infectious disorders
07/22/2008US7402654 PHI 15 DNA polymerase
07/22/2008US7402653 Biologically active peptides
07/22/2008US7402652 Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders
07/22/2008US7402611 Use of amino acids for making medicines for treating to insulin-resistance
07/22/2008US7402600 Nitroderivatives of cardiovascular agents
07/22/2008US7402599 Protein structures and protein fibres
07/22/2008US7402571 Methods and pharmaceutical compositions for healing wounds
07/22/2008US7402570 kits for detecting amplification or elevated expression for diagnosis; genetic engineering; solid phase synthesis
07/22/2008US7402567 Treatment of disease by inducing cell apoptosis
07/22/2008US7402566 variants or fragments of the Drosophilia sog proteins, used in the therapy of alopecia, cancers or neurodegenerative disorders
07/22/2008US7402565 Processes for making acylated insulin
07/22/2008US7402564 ligands or agonists of the kappa opioid receptors, that exhibit low cytochrome P450 inhibition and low penetration into the brain, useful in the prophylaxis or treatment of pain and inflammation
07/22/2008US7402563 EPF derived peptides and therapeutic compositions
07/22/2008US7402562 Composition for stabilizing corneal tissue during or after orthokeratology lens wear
07/22/2008US7402561 Of a human papilloma virus-infected cell; topical administration of an oligopeptide halomethyl ketone inhibitor of a chymotrypsin or chymotrypsin-like protease to decrease the amount of viral DNA in the cell; preferred inhibitor is ala-ala-pro-phe chloromethyl ketone
07/22/2008US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells
07/22/2008US7402559 Composition and method of treatment for urogenital conditions
07/22/2008US7402558 Improved embyros implanting; prenancy
07/22/2008US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine)
07/22/2008US7402556 Prodrugs activated by plasmin and their use in cancer chemotherapy
07/22/2008US7402434 Splice choice antagonists as therapeutic agents
07/22/2008US7402430 Preparing synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders
07/22/2008US7402427 Genomic RNA of paramyxovirus encoding M and F proteins; decreased production of viral particles; suppresses cancer growth
07/22/2008US7402410 Humanized immunoglobulin reactive with α4β7 integrin
07/22/2008US7402401 Determining whether ST receptor protein or mRNA encoding it is present in lymph node; polymerase chain reaction and binding assay
07/22/2008US7402396 Core structure of gp41 from the HIV envelope glycoprotein
07/22/2008US7402395 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
07/22/2008US7402394 Screening for compound that activates or inhibits activity of Aster Associated Protein; over-expression disrupts mitotic spindle assembly and leads to aberrant and abortive mitosis
07/22/2008US7402393 Methods of screening for antagonists of APM1/GZIP
07/22/2008US7402322 Human chorionic gonadotrophin, obtained form urine of pregnant humans, used for prophylaxis of allergies, autoimmune disease, graft versus host disease or as antiinflammatory agents; immunotherapy
07/22/2008US7402315 Peptide of given sequence; fused to glutathione-S-transferase; use in immunoassays and vaccines
07/22/2008US7402314 Antigen peptides; medical diagnosis
07/22/2008US7402311 Composition and method for treating non-bacterial cystitis
07/22/2008US7402310 Deoxyribonuclease, gene encoding same and use thereof
07/22/2008US7402309 Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions
07/22/2008US7402306 Cancer immunotherapy with semi-allogeneic cells
07/22/2008US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders
07/22/2008US7402304 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders
07/22/2008US7402303 Chemokine mutants in the treatment of multiple sclerosis
07/22/2008CA2584456C Composition comprising desmopressin
07/22/2008CA2457056C Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastasis or preventing the recurrence of malignant tumor
07/22/2008CA2384418C Use of cytokines, cells, and mitogens to inhibit graft versus host disease
07/22/2008CA2321933C Fibronectin peptides-based extracellular matrix for wound healing
07/22/2008CA2282706C Adenovirus vectors specific for cells expressing .alpha.-fetoprotein and methods of use thereof
07/22/2008CA2198916C Delivery of solid drug compositions
07/22/2008CA2173324C Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods
07/22/2008CA2163805C Novel activating factor of leukocytes
07/22/2008CA2061579C Cystic fibrosis transmembrane conductance regulator (cftr) protein
07/22/2008CA2017025C Tumor necrosis factor binding protein ii, its purification and antibodies thereto
07/22/2008CA1341577C Expression of biologically active factor xiii
07/19/2008CA2574531A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
07/17/2008WO2008086486A1 Porous objects having immobilized encapsulated biomolecules
07/17/2008WO2008086452A2 Treatment and prevention of alzheimer's disease
07/17/2008WO2008086426A2 Methods for increasing and mobilizing hematopoietic stem cells
07/17/2008WO2008086296A2 Acid ceramidase and cell survival
07/17/2008WO2008086161A1 Macrocyclic hepatitis c protease inhibitors
07/17/2008WO2008086042A2 Preventing infection by a measles or respiratory syncytial virus